Anonymous. Taraxacum officinale. Altern Med Rev 1999;4:112-4.
Berkson BM. A conservative triple antioxidant approach to the treatment of
hepatitis C. Combination of
alpha lipoic acid (thioctic
acid), silymarin, and
selenium: three case
histories. Med Klin 1999;94 Suppl 3:84-9.
Christian JS, Rege RV. Methionine, but not taurine, protects against
formation of canine pigment
gallstones. J Surg Res
1996;61:275-81.
Chuang SE, Kuo ML, Hsu CH, et al. Curcumin-containing diet inhibits
diethylnitrosamine-induced
murine hepatocarcinogenesis.
Carcinogenesis
2000;21:331-5.
Favari L, Perez-Alvarez V. Comparative effects of colchicine and silymarin
on CCl4-chronic liver damage
in rats. Arch Med Res
1997;28:11-7.
Flora K, Hahn M, Rosen H, et al. Milk thistle (Silybum marianum) for the
therapy of liver disease
[see comments]. Am J
Gastroenterol
1998;93:139-43.
Kenney JL, Carlberg KA. The effect of choline and myo-inositol on liver and
carcass fat levels in
aerobically trained rats.
Int J Sports Med
1995;16:114-6.
Kropacova K, Misurova E, Hakova H. Protective and therapeutic effect of
silymarin on the development
of latent liver damage.
Radiats Biol Radioecol
1998;38:411-5.
Lieber CS. Pathogenesis and treatment of liver fibrosis in alcoholics: 1996
update. Dig Dis
1997;15:42-66.
Park EJ, Jeon CH, Ko G, et al. Protective effect of curcumin in rat liver
injury induced by carbon
tetrachloride. J Pharm
Pharmacol 2000;52:437-40.